Menu
Currency
GWAS Study

Multi-omics analyses prioritize disease genes and pathways in hidradenitis suppurativa.

Peacker BL, Ly L, Hwang JC et al.

41548865 PubMed ID
GWAS Study Type
1439544 Participants
112 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PB
Peacker BL
LL
Ly L
HJ
Hwang JC
GK
Gravel-Pucillo K
ZC
Zheng C
WL
Wheless LE
FB
Ferolito BR
CK
Cho K
GJ
Gaziano JM
PA
Pereira AC
HR
Hartman RI
Chapter II

Abstract

Summary of the research findings

Hidradenitis suppurativa is a chronic inflammatory skin condition associated with an increased risk of all-cause mortality. Although it is known to be influenced by genetic and environmental factors, the genetic contributors remain poorly characterized. We performed a large-scale meta-analysis involving patients from the Million Veteran Program, UK Biobank, and FinnGen, including a total of 3941 cases and 1,435,603 controls. We identified 9 genome-wide significant loci, 5 of which have not been previously reported. Using a variant-to-gene analysis pipeline, we mapped these variants to 11 lead genes, supporting prior candidates while revealing previously unreported ones, to our knowledge, including SMPD4 and PSMA4, which we demonstrate are differentially expressed in hidradenitis suppurativa skin lesions. Using expression quantitative trait loci and protein quantitative trait loci, 2-sample Mendelian randomization identified additional genes likely involved in the pathogenesis of hidradenitis suppurativa, including MPO. We subsequently probed the protein interactome network of these candidates to reveal drug targets for prioritization in future studies. These results reaffirm the previously suspected role of KLF5 in hidradenitis suppurativa while linking the pathogenesis of the disease to pathways related to lipid and skin barrier homeostasis, proteasome function, and oxidative stress.

2,864 European ancestry cases, 1,315,903 European ancestry controls, 1,077 African ancestry cases, 119,700 African ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1439544
Total Participants
GWAS
Study Type
No
Replicated
European, African unspecified
Ancestry
U.S., U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.